Oropharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Oropharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
A Phase 2 study of dasatinib in patients with recurrent or metastatic head and neck cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
This update notes the completion of a clinical trial examining ex vivo multimodal imaging of the upper aerodigestive epithelium in head and …
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat [Phase 2]
Phase 2 clinical trial S0011 evaluating gene therapy with surgery followed by chemotherapy and radiotherapy for newly diagnosed head and nec…
-
CLINICAL_TRIALS trial_result · 2012-04-18Clinical Trial Update: Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy [Phase 1]
A Phase 1 trial evaluating whether a low antioxidant diet can help control cachexia in patients with oropharyngeal cancer undergoing chemoth…
-
CLINICAL_TRIALS research · 2012-03-28Clinical Trial Update: Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC [NA]
The document reports a clinical trial evaluating postoperative radiotherapy guided by molecular analysis of surgical margins in oral cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-03-20Clinical Trial Update: Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer [Phase 2]
Clinical trial update for a Phase 2 study evaluating nimotuzumab in combination with neoadjuvant and concurrent chemoradiotherapy for oropha…
-
CLINICAL_TRIALS withdrawal · 2012-01-16Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence [Phase 3]
A Phase 3 trial evaluating chemotherapy and radiation therapy with or without panitumumab after surgery for high-risk advanced head and neck…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC [Phase 3]
Phase 3 trial assessing accelerated radiotherapy with concomitant chemoradiotherapy for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2011-06-23Clinical Trial Update: Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer. [Phase 3]
Phase 3 clinical trial update comparing 3D conformal radiotherapy (3DCRT) with image-guided radiotherapy (IGRT) and analyzing early response…
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis
This clinical trial update describes a feasibility study using F-18-FDG-PET and optical imaging to evaluate radiation-induced oral mucositis…
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia [Phase 3]
Phase 3 clinical trial comparing parotid-sparing intensity-modulated radiation therapy with conventional radiation therapy for oropharyngeal…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: OraTest in Combination With Visual Examination and Visual Examination Alone [Phase 3]
Phase 3 trial assessing OraTest with visual examination versus visual examination alone in head and neck and oropharyngeal cancer; the study…
-
EMA guidance · 2009-02-19European Medicines Agency recommends continued vaccination with Gardasil
The EMA recommends continuing vaccination with Gardasil, endorsing ongoing use of the HPV vaccine for protection against HPV-related disease…
-
CLINICAL_TRIALS research · 2007-08-28Clinical Trial Update: Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating analgesia at the fibula free flap donor site using a peri-neuronal c…
-
CLINICAL_TRIALS trial_result · 2007-05-08Clinical Trial Update: Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 1]
Phase 1 trial of motexafin gadolinium combined with chemotherapy and radiation for advanced head and neck cancer has been terminated.
-
CLINICAL_TRIALS research · 2006-10-26Clinical Trial Update: Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. [Phase 2]
This document provides a Phase 2 clinical trial update of cetuximab with concomitant-boost accelerated radiotherapy for locally advanced oro…